197 related articles for article (PubMed ID: 25696857)
41. Estimating tissue iron burden: current status and future prospects.
Wood JC
Br J Haematol; 2015 Jul; 170(1):15-28. PubMed ID: 25765344
[TBL] [Abstract][Full Text] [Related]
42. Impact of iron assessment by MRI.
Wood JC
Hematology Am Soc Hematol Educ Program; 2011; 2011():443-50. PubMed ID: 22160072
[TBL] [Abstract][Full Text] [Related]
43. [MRI for assessment of iron overload in patients with hematologic disease].
Xiao C; Gu S; Xu Y; Chen Z; Song L; Chang C
Zhonghua Xue Ye Xue Za Zhi; 2015 Dec; 36(12):1039-42. PubMed ID: 26759109
[TBL] [Abstract][Full Text] [Related]
44. Iron overload and toxicity: implications for anesthesiologists.
Shander A; Berth U; Betta J; Javidroozi M
J Clin Anesth; 2012 Aug; 24(5):419-25. PubMed ID: 22658368
[TBL] [Abstract][Full Text] [Related]
45. Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy.
Shander A; Sazama K
Transfusion; 2010 May; 50(5):1144-55. PubMed ID: 20088842
[TBL] [Abstract][Full Text] [Related]
46. Use of magnetic resonance imaging to monitor iron overload.
Wood JC
Hematol Oncol Clin North Am; 2014 Aug; 28(4):747-64, vii. PubMed ID: 25064711
[TBL] [Abstract][Full Text] [Related]
47. Assessmrent of iron overload in thalassaemic patients by magnetic resonance imaging: a pilot study.
Kumar P; Jagannathan NR; Choudhry VP
J Indian Med Assoc; 2007 Oct; 105(10):561-4, 591. PubMed ID: 18383951
[TBL] [Abstract][Full Text] [Related]
48. A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.
Ha SY; Mok AS; Chu WC; Raskalkar DD; Cheuk DK; Chiang AK; Ho MH; Chan GC
Hemoglobin; 2009; 33(5):323-31. PubMed ID: 19814678
[TBL] [Abstract][Full Text] [Related]
49. MRI as an alternative to serum ferritin for diagnosis of iron overload in children in the context of immune response after stem cell transplantation.
Wurschi GW; Mentzel HJ; Herrmann KH; Krumbein I; Beck JF; Reichenbach JR; Kentouche K
Pediatr Transplant; 2019 Dec; 23(8):e13583. PubMed ID: 31535426
[TBL] [Abstract][Full Text] [Related]
50. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
51. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
52. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
[TBL] [Abstract][Full Text] [Related]
53. An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.
Rascon J; Rageliene L; Stankeviciene S; Palionis D; Tamosiunas AE; Valeviciene N; Zvirblis T
Eur J Pediatr; 2014 Sep; 173(9):1137-46. PubMed ID: 24659311
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic efficacy of tests for the detection of iron overload in chronic liver disease.
Valberg LS; Ghent CN; Lloyd DA; Frei JV; Chamberlain MJ
Can Med Assoc J; 1978 Aug; 119(3):229-36. PubMed ID: 679127
[TBL] [Abstract][Full Text] [Related]
55. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
56. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients.
Hashemieh M; Azarkeivan A; Akhlaghpoor S; Shirkavand A; Sheibani K
Arch Iran Med; 2012 Feb; 15(2):91-4. PubMed ID: 22292579
[TBL] [Abstract][Full Text] [Related]
57. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
[TBL] [Abstract][Full Text] [Related]
58. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major.
Au WY; Lam WW; Chu W; Tam S; Wong WK; Liang R; Ha SY
Haematologica; 2008 Jan; 93(1):116-9. PubMed ID: 18166794
[TBL] [Abstract][Full Text] [Related]
59. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
Daar S; Pathare AV
Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
[TBL] [Abstract][Full Text] [Related]
60. Dual-energy CT for liver iron quantification in patients with haematological disorders.
Werner S; Krauss B; Haberland U; Bongers M; Starke U; Bakchoul T; Enkel S; Nikolaou K; Horger M
Eur Radiol; 2019 Jun; 29(6):2868-2877. PubMed ID: 30406312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
